login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANNOVIS BIO (ANVS) Stock News
USA
- NYSE:ANVS -
US03615A1088
-
Common Stock
2.2
USD
-0.07 (-3.08%)
Last: 10/9/2025, 7:13:17 PM
2.2008
USD
+0 (+0.04%)
After Hours:
10/9/2025, 7:13:17 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ANVS Latest News, Press Relases and Analysis
All
Press Releases
12 hours ago - By: Annovis Bio Inc.
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
12 hours ago - By: Annovis Bio Inc.
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
15 days ago - By: Annovis Bio Inc.
Annovis Appoints Mark Guerin as Chief Financial Officer
15 days ago - By: Annovis Bio Inc.
- Mentions:
TRAW
Annovis Appoints Mark Guerin as Chief Financial Officer
4 months ago - By: Annovis Bio Inc.
Annovis to Host Webinar and Live Q&A on June 24, 2025
7 months ago - By: Annovis Bio Inc.
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
8 months ago - By: Annovis Bio, Inc.
Annovis to Host Patients’ Live Forum on February 27, 2025
24 days ago - By: Annovis Bio Inc.
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
24 days ago - By: Annovis Bio Inc.
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
a month ago - By: Benzinga
- Mentions:
WTFC
BWA
CHE
MTB
...
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday
a month ago - By: Annovis Bio Inc.
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2 months ago - By: The Motley Fool
Annovis Bio Narrows Loss in Q2
2 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
2 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
2 months ago - By: Annovis Bio Inc.
Annovis Completes Full Patent Transfer to Crystal Buntanetap
3 months ago - By: Benzinga
- Mentions:
SHOT
BLMZ
TWG
AGYS
...
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket
4 months ago - By: Annovis Bio Inc.
Annovis to Attend the AAIC 2025 with Four Poster Presentations
4 months ago - By: Annovis Bio Inc.
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
4 months ago - By: Annovis Bio Inc.
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
4 months ago - By: Annovis Bio Inc.
Annovis to Host Webinar and Live Q&A on June 24, 2025
5 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
5 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
5 months ago - By: Annovis Bio Inc.
Annovis Bio Appoints Hui Liu as Director of Biostatistics
7 months ago - By: Annovis Bio Inc.
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
7 months ago - By: Annovis Bio Inc.
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
7 months ago - By: Annovis Bio Inc.
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
7 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
7 months ago - By: Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
7 months ago - By: Annovis Bio Inc.
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
8 months ago - By: Annovis Bio, Inc.
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
8 months ago - By: Annovis Bio, Inc.
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease
Please enable JavaScript to continue using this application.